Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • 5-HT Receptor
    (1)
  • ALK
    (1)
  • Adrenergic Receptor
    (2)
  • Dopamine Receptor
    (1)
  • Drug Metabolite
    (1)
  • Others
    (8)
Filter
Search Result
Results for "

product7/Pergolide-mesylate-salt.html

" in TargetMol Product Catalog
  • Inhibitors & Agonists
    12
    TargetMol | Activity
  • Dye Reagents
    1
    TargetMol | inventory
CEP-28122 mesylate salt (1022958-60-6 free base)
T10759
CEP-28122 mesylate salt (1022958-60-6 free base) is a highly selective orally active ALK inhibitor (IC50: 1.9 nM in an enzyme-based TRF assay).
  • $39
In Stock
Size
QTY
TargetMol | Inhibitor Sale
AST5902 mesylate(2412155-74-7 free base)
T8945L2412155-75-8
AST5902 mesylate is principal metabolite of Alflutinib in vivo. AST5902 mesylate exerts antineoplastic activity.
  • $137
In Stock
Size
QTY
TargetMol | Inhibitor Sale
7-hydroxy Coumarin sulfate (potassium salt)
T373651135316-80-1
7-hydroxy Coumarin sulfate is a phase II metabolite of coumarin that can be used as an internal standard for the analysis of 7-hydroxy coumarin metabolism using GC- or LC-MS.
  • $110
35 days
Size
QTY
CEP-28122 mesylate salt
T72317
CEP-28122 mesylate salt, a diaminopyrimidine derivative, is a potent, selective, and orally bioavailable ALK (anaplastic lymphoma kinase) inhibitor with an IC50 value of 1.9 nM against recombinant ALK kinase activity. It shows antitumor efficacy in ALK-positive human cancer models and has favorable pharmacodynamic and pharmacokinetic profiles.
  • $98
5 days
Size
QTY
Isoetharine mesylate salt
T49837279-75-6
Isoetharine mesylate salt (Isoetarine mesilate) is a β-adrenergic receptor agonist. it also is pregnane X receptor (PXR) activator capable of upregulating CYP450 expression.
  • $60
In Stock
Size
QTY
7-hydroxy Methotrexate (sodium salt)
T37269
7-hydroxy Methotrexate (sodium salt) is the major metabolite of Methotrexate (T1485).
  • $296
35 days
Size
QTY
7-Chlorokynurenic acid sodium salt
T101911263094-00-3
7-Chlorokynurenic acid sodium salt (7-CKA sodium salt) is a potent and selective antagonist of the glycine B coagonist site of the NMDA receptor (IC50: 0.56 μM) and a potent inhibitor of the reuptake of glutamate into synaptic vesicles (Ki: 0.59 μM).
  • $44
5 days
Size
QTY
Orlistat Degradation Product (sodium salt)
T35788
Orlistat degradation product is a degradation product of the digestive lipase inhibitor orlistat . It is formed via hydrolytic and thermal degradation as well as digestion by human carboxyl ester lipase.
  • $585
35 days
Size
QTY
D-Sedoheptulose-7-phosphate (barium salt)
T3798917187-72-3
D-Sedoheptulose-7-phosphate is an intermediate in the pentose phosphate pathway. [1] [2] In this pathway, transaldolase catalyzes the transfer of a three carbon dihydroxyacetone moiety from D-sedoheptulose-7-phosphate to glyceraldehyde-3-phosphate to generate D-fructose-6-phosphate . D-Sedoheptulose-7-phosphate is also an intermediate in carbon fixation in photosynthetic organisms, as well as in the biosynthesis of lipopolysaccharide, amino acids, secondary metabolites, and antibiotics. [3]
  • $296
35 days
Size
QTY
Pergolide mesylate
T222666104-23-2
Pergolide mesylate salt(LY127809) is a long-acting dopamine agonist which has been used to treat PARKINSON DISEASE and HYPERPROLACTINEMIA but withdrawn from some markets due to potential for HEART VALVE DISEASES.
  • $47
In Stock
Size
QTY
7-hydroxy Coumarin Glucuronide (sodium salt)
T37364168286-98-4
7-hydroxy Coumarin glucuronide is a 7-hydroxy coumarin phase II metabolite that can be used as a standard for the analysis of 7-hydroxy coumarin metabolism.
  • $296
35 days
Size
QTY
GLP-1(7-37) TFA salt
T64553
The truncated glucagon-like peptides GLP-1(7-37) is naturally occurring peptide product of the preproglucagon gene that are synthesized primarily in the intestine and acts as incretin that are released from the intestine into the bloodstream in response to food and stimulate insulin secretion. GLP-1(7-37) produced a dose-related enhancement of the glucose-stimulated increase in plasma insulin concentration and an increased rate of glucose infusion in Sprague-Dawley Rats at a dosing rang of 0.5, 5, or 50 pmol/min/kg. Further, infusion of GLP-1(7-37) for 60 mins produced a small transitory increase in plasma insulin concentration in fasted rats and fed rats and a slight transitory decrease in plasma glucose concentration. Moreover, GLP-1(7-37) (5 pmol/min/kg IV) infusion for 6 h in Sprague-Dawley rats produced a sustained increase in plasma insulin concentration relative to levels in rats infused with vehicle[1].
    7-10 days
    Inquiry